Boston-based Vertex Pharmaceuticals developed Journavx, a non-addictive medication for people with moderate to severe acute pain. AP Photo/Bill Sikes A novel painkiller approved Thursday by the FDA promises to relieve post-surgical suffering while avoiding the addictive qualities of opioid medications. Boston-based Vertex Pharmaceuticals, which developed the oral treatment called Journavx for …
https://news.northeastern.edu/2025/01/31/non-addictive-painkiller-journavx/

